Chronic inflammation is behind more than half of all deaths. New research shows stimulating the vagus nerve may stop it.
Scientists are shedding new light on an innovative treatment that may combat chronic inflammation—the root of many deadly diseases—without relying on traditional medications.
Vagus nerve stimulation, a technique that sends mild electrical pulses to the body's longest cranial nerve, is showing promise in resetting the immune system and reducing persistent inflammation.
Chronic inflammation is linked to over half of all global deaths and contributes to conditions like heart disease, diabetes, cancer, and autoimmune disorders.
By targeting the vagus nerve, which helps regulate immune function, researchers at the Feinstein Institutes for Medical Research hope to stop disease at its source.
This approach, known as bioelectronic medicine, is gaining traction as a groundbreaking alternative to drug-based therapies. The vagus nerve acts like a command center, directing the immune system’s inflammatory response.
When it fails, the body stays on high alert—leading to lasting damage. Stimulating this nerve helps rebalance that response, curbing the overproduction of harmful inflammatory molecules.
From mood disorders to gut health, and even weight loss, vagus nerve stimulation could represent a revolution in how we treat—and prevent—chronic illness.
On May 21, 2024 BioElectronics Corp announced in a PR that it filed a new utility patent application with the USPTO. The patent application focuses on a non-invasive method for treating chronic inflammation by stimulating the vagus nerve.
The company's research, including a double-blind canine study, suggests that PSWT can reduce systemic discomfort associated with chronic inflammation.
Go Biel
Scientists are shedding new light on an innovative treatment that may combat chronic inflammation—the root of many deadly diseases—without relying on traditional medications.
Vagus nerve stimulation, a technique that sends mild electrical pulses to the body's longest cranial nerve, is showing promise in resetting the immune system and reducing persistent inflammation.
Chronic inflammation is linked to over half of all global deaths and contributes to conditions like heart disease, diabetes, cancer, and autoimmune disorders.
By targeting the vagus nerve, which helps regulate immune function, researchers at the Feinstein Institutes for Medical Research hope to stop disease at its source.
This approach, known as bioelectronic medicine, is gaining traction as a groundbreaking alternative to drug-based therapies. The vagus nerve acts like a command center, directing the immune system’s inflammatory response.
When it fails, the body stays on high alert—leading to lasting damage. Stimulating this nerve helps rebalance that response, curbing the overproduction of harmful inflammatory molecules.
From mood disorders to gut health, and even weight loss, vagus nerve stimulation could represent a revolution in how we treat—and prevent—chronic illness.
On May 21, 2024 BioElectronics Corp announced in a PR that it filed a new utility patent application with the USPTO. The patent application focuses on a non-invasive method for treating chronic inflammation by stimulating the vagus nerve.
The company's research, including a double-blind canine study, suggests that PSWT can reduce systemic discomfort associated with chronic inflammation.
Go Biel
1
